MwanzoICY • FRA
add
Incyte Corp
Bei iliyotangulia
€ 52.24
Bei za siku
€ 52.56 - € 52.56
Bei za mwaka
€ 49.00 - € 78.52
Thamani ya kampuni katika soko
11.56B USD
Wastani wa hisa zilizouzwa
41.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.05B | 19.53% |
Matumizi ya uendeshaji wa biashara | 361.67M | 7.54% |
Mapato halisi | 158.20M | -6.69% |
Kiwango cha faida halisi | 15.03 | -21.92% |
Mapato kwa kila hisa | 1.16 | 81.25% |
EBITDA | 239.82M | 110.11% |
Asilimia ya kodi ya mapato | 32.45% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 2.41B | -37.45% |
Jumla ya mali | 5.75B | -19.43% |
Jumla ya dhima | 2.08B | 19.55% |
Jumla ya hisa | 3.67B | — |
hisa zilizosalia | 193.57M | — |
Uwiano wa bei na thamani | 2.76 | — |
Faida inayotokana na mali | 9.71% | — |
Faida inayotokana mtaji | 15.06% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 158.20M | -6.69% |
Pesa kutokana na shughuli | 266.07M | 21.60% |
Pesa kutokana na uwekezaji | 1.10M | 101.50% |
Pesa kutokana na ufadhili | -12.68M | -2.12% |
Mabadiliko halisi ya pesa taslimu | 253.94M | 91.49% |
Mtiririko huru wa pesa | 275.84M | -0.51% |
Kuhusu
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2002
Makao Makuu
Tovuti
Wafanyakazi
2,617
